WC
KERX

Woodstock Corp’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Woodstock Corp’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-47,017
Closed -$276K – 163
2016
Q4 		$276K Sell
47,017
-9,576
-17% -$52.3K 0.06% 140
2016
Q3 		$301K Hold
56,593
– – 0.06% 136
2016
Q2 		$375K Buy
56,593
+5
+0% +$28 0.08% 124
2016
Q1 		$264K Hold
56,588
– – 0.06% 137
2015
Q4 		$286K Hold
56,588
– – 0.06% 125
2015
Q3 		$199K Hold
56,588
– – 0.05% 143
2015
Q2 		$565K Hold
56,588
– – 0.11% 116
2015
Q1 		$720K Buy
+56,588
New +$727K 0.13% 108

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Woodstock Corp's KERX Position: Q1 2017 in Review

Woodstock Corp sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2017, closing a stake of 47,017 shares — an estimated $276K sold.

Woodstock Corp first reported a position in KERX in Q1 2015 and held it in 8 quarters. The position peaked at $720K in Q1 2015. 119 funds tracked by Wall St. Rank hold KERX as of Q1 2017.

  • Woodstock Corp reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Woodstock Corp sold 47,017 Keryx Biopharmaceuticals Inc shares in Q1 2017, an estimated $276K.
  • Woodstock Corp first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 8 quarters.
  • Woodstock Corp's Keryx Biopharmaceuticals Inc position peaked at $720K in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2017.

Based on Woodstock Corp's 13F filing for Q1 2017, filed 5 Apr 2017.